For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Kinnate Biopharma Inc.

USPTO Granted Patents = 14

Forward Citations = 30

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Toufike Kanouni (13 out of 85 patents)

Stephen W Kaldor (9 out of 66 patents)

Robert Steven Kania (8 out of 39 patents)

4. Jason M Cox (8 out of 32 patents)

5. Eric A Murphy (8 out of 15 patents)

6. John S Tyhonas (7 out of 15 patents)

7. Lee D Arnold (5 out of 16 patents)

8. Young K Chen (1 out of 63 patents)

9. Xiaohu S Ouyang (1 out of 1 patent)

10. Subhas J Chakravorty (1 out of 1 patent)

11. Eric Martin (1 out of 1 patent)

12. Aleksandra Franovic (1 out of 1 patent)

13. Richard Thomas Williams (1 out of 1 patent)

14. Ken Kobayashi (1 out of 1 patent)

15. Nichol L G Miller (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12122800 - Inhibitors of MEK kinase (2024-10-22),

2. 11918587 - Treatment of cancer with a RAF inhibitor (2024-03-05),

3. 11814384 - Inhibtors of Raf kinases (2023-11-14),

4. 11780862 - Inhibitors of MEK kinase (2023-10-10),

5. 11753395 - Inhibitors of MET kinase (2023-09-12),

6. 11746095 - Inhibtors of RAF kinases (2023-09-05),

7. 11667634 - Inhibitors of RAF kinases (2023-06-06),

8. 11407737 - Inhibitors of RAF kinases (2022-08-09),

9. 11390618 - Inhibitors of cyclin-dependent kinases (2022-07-19),

10. 11377431 - Inhibitors of RAF kinases (2022-07-05),

11. 11345681 - Inhibitors of fibroblast growth factor receptor kinases (2022-05-31),

12. 11098031 - Inhibitors of RAF kinases (2021-08-24),

13. 10927111 - Inhibitors of RAF kinases (2021-02-23),

14. 10894788 - Inhibitors of cyclin-dependent kinases (2021-01-19),

Kinnate Biopharma Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of precision oncology therapies. The company's goal is to develop targeted therapies for patients with genetically defined cancers by leveraging its proprietary platform. Kinnate's innovative approach has the potential to revolutionize cancer treatment and improve outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#369 in San Diego, CA

#5,156 in California

#21,638 in US

#40,937 in the World

San Diego, CA, United States of America

Kinnate Biopharma Inc.

Forward Citations = 30

15 inventors:

Toufike Kanouni (13 out of 85 patents)

Stephen W Kaldor (9 out of 66 patents)

Robert Steven Kania (8 out of 39 patents)

4. Jason M Cox (8 out of 32 patents)

5. Eric A Murphy (8 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…